AMGEN INC Prepaid & Other Current Assets 2008-2026 | AMGN
Beta
What is prepaid & other current assets?
Prepaid and other current assets include advance payments and other assets expected to be consumed or converted to cash within one year.
What is AMGEN INC's current prepaid & other current assets?
AMGEN INC (AMGN) annual prepaid & other current assets for 2025 was $4.13B, a 26.12% increase from 2024. AMGEN INC prepaid & other current assets for the quarter ending March 31, 2026 was $4.11B.
What was AMGEN INC's prepaid & other current assets in 2024?
AMGEN INC annual prepaid & other current assets for 2024 was $3.28B, a 25.94% increase from 2023.
What was AMGEN INC's prepaid & other current assets in 2023?
AMGEN INC annual prepaid & other current assets for 2023 was $2.60B, a 8.96% increase from 2022.
What is AMGEN INC's 5-year prepaid & other current assets CAGR?
AMGEN INC prepaid & other current assets grew at a compound annual growth rate (CAGR) of 14.73% from FY2020 to FY2025, going from $2.08B to $4.13B over 5 years.
Prepaid & Other Current Assets History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+14.7%
FY2020
$2.08B
→
FY2025
$4.13B
080910111213141516171819202122232425
5 years selected
Prepaid & Other Current Assets History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.13B | +26.1% | 10-K |
| FY2024 | $3.28B | +25.9% | 10-K |
| FY2023 | $2.60B | +9.0% | 10-K |
| FY2022 | $2.39B | +0.9% | 10-K |
| FY2021 | $2.37B | +13.9% | 10-K |
| FY2020 | $2.08B | +10.1% | 10-K |
| FY2019 | $1.89B | +5.2% | 10-K |
| FY2018 | $1.79B | +3.9% | 10-K |
| FY2017 | $1.73B | -14.3% | 10-K |
| FY2016 | $2.02B | +18.3% | 10-K |
| FY2015 | $1.70B | -31.7% | 10-K |
| FY2014 | $2.49B | +10.8% | 10-K |
| FY2013 | $2.25B | +19.3% | 10-K |
| FY2012 | $1.89B | +20.0% | 10-K |
| FY2011 | $1.57B | +16.4% | 10-K |
| FY2010 | $1.35B | +16.3% | 10-K |
| FY2009 | $1.16B | -23.7% | 10-K |
| FY2008 | $1.52B | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →